Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of SPDEF gene inhibitor in preparation of medicine for enhancing sensitivity of lung mucus adenocarcinoma cells to cis-platinum

A technique for gene suppression and mucinous adenocarcinoma, applied in drug combinations, active ingredients of hydroxyl compounds, antineoplastic drugs, etc., to achieve the effects of inhibiting expression, promoting apoptosis, and enhancing sensitivity

Active Publication Date: 2021-08-27
SHANGHAI PUTUO DISTRICT CENT HOSPITAL
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There is no report on the application of resveratrol in mucinous adenocarcinoma of the lung, so we conducted further research on whether resveratrol can be used as a potential drug for the treatment of mucinous adenocarcinoma of the lung, in order to provide a basis for the treatment of mucinous adenocarcinoma of the lung. new treatment options

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of SPDEF gene inhibitor in preparation of medicine for enhancing sensitivity of lung mucus adenocarcinoma cells to cis-platinum
  • Application of SPDEF gene inhibitor in preparation of medicine for enhancing sensitivity of lung mucus adenocarcinoma cells to cis-platinum
  • Application of SPDEF gene inhibitor in preparation of medicine for enhancing sensitivity of lung mucus adenocarcinoma cells to cis-platinum

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0038] The technical solutions of the present invention will be further described below in conjunction with the drawings and embodiments. The experimental method that does not indicate specific condition in the embodiment, generally according to conventional conditions, such as people such as Sambrook, molecular cloning: the condition described in the laboratory handbook (NewYork: Cold Spring Harbor Laboratory Press, 1989), or according to manufacturer's suggested conditions.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an application of an SPDEF gene inhibitor in the preparation of a medicine for enhancing the sensitivity of lung mucous adenocarcinoma cells to cis-platinum. The sensitivity of patients to cis-platinum treatment can be enhanced by inhibiting the expression quantity of SPDEF genes in the lung mucous adenocarcinoma cells of the patients. The invention also discloses a combined anti-pulmonary adenocarcinoma pharmaceutical composition. The pharmaceutical composition comprises the SPDEF gene inhibitor and the cis-platinum, and compared with the single use of the cis-platinum as an anti-cancer drug, the combined use of the SPDEF gene inhibitor and the cis-platinum can further promote the apoptosis of pulmonary adenocarcinoma cells.

Description

technical field [0001] The invention relates to the field of biotechnology, in particular to the application of an SPDEF gene inhibitor in the preparation of drugs for enhancing the sensitivity of lung mucinous adenocarcinoma cells to cisplatin. Background technique [0002] Lung cancer is one of the malignant tumors with the highest incidence and mortality rate, which seriously threatens human health. Among the types of lung cancer, non-small cell lung cancer (NSCLC, including lung adenocarcinoma, lung squamous cell carcinoma and large cell carcinoma) is the most common pathological type of lung cancer, accounting for more than 70% of the total number of lung cancers, and the proportion of lung adenocarcinoma is Upward trend. Mucinous adenocarcinoma of the lung is a distinct subtype of lung adenocarcinoma, accounting for approximately 5% of all lung adenocarcinomas. Unlike other lung adenocarcinomas, the treatment options for mucinous adenocarcinoma of the lung are limite...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K45/06A61K31/05A61K33/243A61K31/7088A61P11/00A61P35/00C12Q1/6886
CPCA61K45/06A61K31/05A61K33/243A61K31/7088A61P11/00A61P35/00C12Q1/6886C12Q2600/106C12Q2600/158A61K2300/00Y02A50/30
Inventor 倪振华王雄彪林玉华
Owner SHANGHAI PUTUO DISTRICT CENT HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com